BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17203463)

  • 21. Resveratrol modulates roscovitine-mediated cell cycle arrest of human MCF-7 breast cancer cells.
    Wesierska-Gadek J; Kramer MP; Maurer M
    Food Chem Toxicol; 2008 Apr; 46(4):1327-33. PubMed ID: 17933449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cadmium induces phosphorylation of p53 at serine 15 in MCF-7 cells.
    Matsuoka M; Igisu H
    Biochem Biophys Res Commun; 2001 Apr; 282(5):1120-5. PubMed ID: 11302731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Action of resveratrol alone or in combination with roscovitine, a CDK inhibitor, on cell cycle progression in human HL-60 leukemia cells.
    Komina O; Wesierska-Gadek J
    Biochem Pharmacol; 2008 Dec; 76(11):1554-62. PubMed ID: 18761329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional p53 in cells contributes to the anticancer effect of the cyclin-dependent kinase inhibitor roscovitine.
    Paprskárová M; Krystof V; Jorda R; Dzubák P; Hajdúch M; Wesierska-Gadek J; Strnad M
    J Cell Biochem; 2009 Jun; 107(3):428-37. PubMed ID: 19308936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Common and reversible regulation of wild-type p53 function and of ribosomal biogenesis by protein kinases in human cells.
    David-Pfeuty T; Nouvian-Dooghe Y; Sirri V; Roussel P; Hernandez-Verdun D
    Oncogene; 2001 Sep; 20(42):5951-63. PubMed ID: 11593402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced roscovitine-induced apoptosis is mediated by a caspase-3-like activity in deoxyadenosine-resistant mouse leukemia L1210 cells.
    Somerville L; Cory JG
    Anticancer Res; 2000; 20(5B):3347-55. PubMed ID: 11131634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cyclin-dependent kinase inhibitor roscovitine inhibits RNA synthesis and triggers nuclear accumulation of p53 that is unmodified at Ser15 and Lys382.
    Ljungman M; Paulsen MT
    Mol Pharmacol; 2001 Oct; 60(4):785-9. PubMed ID: 11562441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation.
    Rui Y; Xu Z; Lin S; Li Q; Rui H; Luo W; Zhou HM; Cheung PY; Wu Z; Ye Z; Li P; Han J; Lin SC
    EMBO J; 2004 Nov; 23(23):4583-94. PubMed ID: 15526030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P53-mediated cell cycle arrest and apoptosis through a caspase-3- independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells.
    Cui Q; Yu JH; Wu JN; Tashiro S; Onodera S; Minami M; Ikejima T
    Acta Pharmacol Sin; 2007 Jul; 28(7):1057-66. PubMed ID: 17588343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclin-dependent kinase inhibitors sensitize tumor cells to nutlin-induced apoptosis: a potent drug combination.
    Cheok CF; Dey A; Lane DP
    Mol Cancer Res; 2007 Nov; 5(11):1133-45. PubMed ID: 18025259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potent inhibitors of cyclin-dependent kinase 2 induce nuclear accumulation of wild-type p53 and nucleolar fragmentation in human untransformed and tumor-derived cells.
    David-Pfeuty T
    Oncogene; 1999 Dec; 18(52):7409-22. PubMed ID: 10602500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human embryonic stem cells display a pronounced sensitivity to the cyclin dependent kinase inhibitor Roscovitine.
    Videla-Richardson GA; Furmento VA; Garcia CP; Morris-Hanon O; Sevlever GE; Romorini L; Scassa ME
    BMC Mol Cell Biol; 2019 Aug; 20(1):40. PubMed ID: 31462218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emodin induces a reactive oxygen species-dependent and ATM-p53-Bax mediated cytotoxicity in lung cancer cells.
    Lai JM; Chang JT; Wen CL; Hsu SL
    Eur J Pharmacol; 2009 Nov; 623(1-3):1-9. PubMed ID: 19744477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis.
    D'Orazi G; Cecchinelli B; Bruno T; Manni I; Higashimoto Y; Saito S; Gostissa M; Coen S; Marchetti A; Del Sal G; Piaggio G; Fanciulli M; Appella E; Soddu S
    Nat Cell Biol; 2002 Jan; 4(1):11-9. PubMed ID: 11780126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benzo(a)pyrene increases phosphorylation of p53 at serine 392 in relation to p53 induction and cell death in MCF-7 cells.
    Tampio M; Loikkanen J; Myllynen P; Mertanen A; Vähäkangas KH
    Toxicol Lett; 2008 May; 178(3):152-9. PubMed ID: 18440733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Homeodomain-interacting protein kinase-2 activity and p53 phosphorylation are critical events for cisplatin-mediated apoptosis.
    Di Stefano V; Rinaldo C; Sacchi A; Soddu S; D'Orazi G
    Exp Cell Res; 2004 Feb; 293(2):311-20. PubMed ID: 14729469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asiatic acid, a triterpene, induces apoptosis and cell cycle arrest through activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways in human breast cancer cells.
    Hsu YL; Kuo PL; Lin LT; Lin CC
    J Pharmacol Exp Ther; 2005 Apr; 313(1):333-44. PubMed ID: 15626723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase.
    She QB; Bode AM; Ma WY; Chen NY; Dong Z
    Cancer Res; 2001 Feb; 61(4):1604-10. PubMed ID: 11245472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.